Unilife Newsroom Blog

Unilife Corp (NASDAQ: UNIS) launches Unitract.com

Unilife Corporation has launched Unitract.com to support the commercial release of its Unitract™ 1 mL clinical safety syringes. The web site contains in-depth product information on Unitract™’s technology, features and benefits as well as product variants and availability, a download section with training materials, and videos that provide a detailed look at functionality.

Unitract syringes provide an automatic choice for safe, simple injections. A uniquely passive safety mechanism allows operators to control the rate of needle retraction directly from the body to help protect those at risk of infection from needlestick injuries and aerosol. US-made and intuitive for use, Unitract™ 1mL syringes are helping to redefine injection safety standards for healthcare workers and patients which self-administer prescription medication.

Unitract Web Site